Share of Canadians who approve of psilocybin-assisted psychotherapy for PTSD in 2021
As of 2021, around 41 percent of all Canadians aged 18 years and older stated that they approved of medical use of psilocybin-assisted psychotherapy for treating post-traumatic stress disorders. This statistic illustrates the percentage of Canadian adults who approved of the medical use of psilocybin-assisted psychotherapy to treat post-traumatic stress disorders in 2021.